Chemotherapy-induced nausea and vomiting (CINV) is influenced by several risk factors including patient-specific characteristics and treatment-related factors. Understanding these risk factors is crucial for tailoring effective antiemetic prophylaxis and improving patient outcomes during chemotherapy.